BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 11694335)

  • 21. The caspase 8 inhibitor c-FLIP(L) modulates T-cell receptor-induced proliferation but not activation-induced cell death of lymphocytes.
    Lens SM; Kataoka T; Fortner KA; Tinel A; Ferrero I; MacDonald RH; Hahne M; Beermann F; Attinger A; Orbea HA; Budd RC; Tschopp J
    Mol Cell Biol; 2002 Aug; 22(15):5419-33. PubMed ID: 12101236
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Constitutive caspase activation and impaired death-inducing signaling complex formation in CD95-resistant, long-term activated, antigen-specific T cells.
    Strauss G; Knape I; Melzner I; Debatin KM
    J Immunol; 2003 Aug; 171(3):1172-82. PubMed ID: 12874203
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The caspase-8 inhibitor FLIP promotes activation of NF-kappaB and Erk signaling pathways.
    Kataoka T; Budd RC; Holler N; Thome M; Martinon F; Irmler M; Burns K; Hahne M; Kennedy N; Kovacsovics M; Tschopp J
    Curr Biol; 2000 Jun; 10(11):640-8. PubMed ID: 10837247
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Resistance of short term activated T cells to CD95-mediated apoptosis correlates with de novo protein synthesis of c-FLIPshort.
    Schmitz I; Weyd H; Krueger A; Baumann S; Fas SC; Krammer PH; Kirchhoff S
    J Immunol; 2004 Feb; 172(4):2194-200. PubMed ID: 14764686
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of death receptor signals by cellular FLIP.
    Irmler M; Thome M; Hahne M; Schneider P; Hofmann K; Steiner V; Bodmer JL; Schröter M; Burns K; Mattmann C; Rimoldi D; French LE; Tschopp J
    Nature; 1997 Jul; 388(6638):190-5. PubMed ID: 9217161
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential regulation of Fas-mediated apoptosis of rheumatoid synoviocytes by tumor necrosis factor alpha and basic fibroblast growth factor is associated with the expression of apoptosis-related molecules.
    Kobayashi T; Okamoto K; Kobata T; Hasunuma T; Kato T; Hamada H; Nishioka K
    Arthritis Rheum; 2000 May; 43(5):1106-14. PubMed ID: 10817565
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fas aggregation does not correlate with Fas-mediated apoptosis.
    Lee Y; Shacter E
    J Immunol; 2001 Jul; 167(1):82-9. PubMed ID: 11418635
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phosphatidylinositol 3-kinase/Akt signaling controls endothelial cell sensitivity to Fas-mediated apoptosis via regulation of FLICE-inhibitory protein (FLIP).
    Suhara T; Mano T; Oliveira BE; Walsh K
    Circ Res; 2001 Jul; 89(1):13-9. PubMed ID: 11440972
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cellular FLIP long form augments caspase activity and death of T cells through heterodimerization with and activation of caspase-8.
    Dohrman A; Russell JQ; Cuenin S; Fortner K; Tschopp J; Budd RC
    J Immunol; 2005 Jul; 175(1):311-8. PubMed ID: 15972663
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Resistance of human ovarian cancer cells to tumor necrosis factor alpha is a consequence of nuclear factor kappaB-mediated induction of Fas-associated death domain-like interleukin-1beta-converting enzyme-like inhibitory protein.
    Xiao CW; Yan X; Li Y; Reddy SA; Tsang BK
    Endocrinology; 2003 Feb; 144(2):623-30. PubMed ID: 12538625
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Monitoring of caspase-8/FLICE processing and activation upon Fas stimulation with novel antibodies directed against a cleavage site for caspase-8 and its substrate, FLICE-like inhibitory protein (FLIP).
    Niikura Y; Nonaka T; Imajoh-Ohmi S
    J Biochem; 2002 Jul; 132(1):53-62. PubMed ID: 12097160
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Induction of apoptosis in 9-nitrocamptothecin-treated DU145 human prostate carcinoma cells correlates with de novo synthesis of CD95 and CD95 ligand and down-regulation of c-FLIP(short).
    Chatterjee D; Schmitz I; Krueger A; Yeung K; Kirchhoff S; Krammer PH; Peter ME; Wyche JH; Pantazis P
    Cancer Res; 2001 Oct; 61(19):7148-54. PubMed ID: 11585748
    [TBL] [Abstract][Full Text] [Related]  

  • 33. c-FLICE inhibitory protein expression inhibits T-cell activation.
    Tai TS; Fang LW; Lai MZ
    Cell Death Differ; 2004 Jan; 11(1):69-79. PubMed ID: 12970675
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular basis of rifampicin-induced inhibition of anti-CD95-induced apoptosis of peripheral blood T lymphocytes: the role of CD95 ligand and FLIPs.
    Gollapudi S; Jaidka S; Gupta S
    J Clin Immunol; 2003 Jan; 23(1):11-22. PubMed ID: 12645856
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The inhibitor of death receptor signaling, FLICE-inhibitory protein defines a new class of tumor progression factors.
    Djerbi M; Screpanti V; Catrina AI; Bogen B; Biberfeld P; Grandien A
    J Exp Med; 1999 Oct; 190(7):1025-32. PubMed ID: 10510092
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytokine regulation of human intestinal primary epithelial cell susceptibility to Fas-mediated apoptosis.
    Martin CA; Panja A
    Am J Physiol Gastrointest Liver Physiol; 2002 Jan; 282(1):G92-G104. PubMed ID: 11751162
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The expression of pro- and anti-apoptosis Bcl-2 family proteins in lymphocytes from patients with multiple sclerosis.
    Sharief MK; Douglas M; Noori M; Semra YK
    J Neuroimmunol; 2002 Apr; 125(1-2):155-62. PubMed ID: 11960652
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of antiapoptotic proteins in tumor necrosis factor-related apoptosis-inducing ligand and cisplatin-augmented apoptosis.
    Kim JH; Ajaz M; Lokshin A; Lee YJ
    Clin Cancer Res; 2003 Aug; 9(8):3134-41. PubMed ID: 12912965
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The inhibition of apoptosis in myositis and in normal muscle cells.
    Nagaraju K; Casciola-Rosen L; Rosen A; Thompson C; Loeffler L; Parker T; Danning C; Rochon PJ; Gillespie J; Plotz P
    J Immunol; 2000 May; 164(10):5459-65. PubMed ID: 10799913
    [TBL] [Abstract][Full Text] [Related]  

  • 40. c-FLIP mediates resistance of Hodgkin/Reed-Sternberg cells to death receptor-induced apoptosis.
    Mathas S; Lietz A; Anagnostopoulos I; Hummel F; Wiesner B; Janz M; Jundt F; Hirsch B; Jöhrens-Leder K; Vornlocher HP; Bommert K; Stein H; Dörken B
    J Exp Med; 2004 Apr; 199(8):1041-52. PubMed ID: 15078899
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.